Selected article for: "alkaline phosphatase and ALP alkaline phosphatase"

Title: 2017 ACVIM Forum Research Abstract Program
  • Document date: 2017_6_15
  • ID: ri2w5iby_667
    Snippet: There were no significant abnormalities on CBC, urinalysis, or pre-and postprandial bile acids. Mild elevations in serum alkaline phosphatase (ALP) occurred at 4 and 6 weeks, more frequently with capsule and oil formulations at 300 mg/day. All dogs experienced diarrhea; presence, onset, and severity did not correlate with formulation or dose......
    Document: There were no significant abnormalities on CBC, urinalysis, or pre-and postprandial bile acids. Mild elevations in serum alkaline phosphatase (ALP) occurred at 4 and 6 weeks, more frequently with capsule and oil formulations at 300 mg/day. All dogs experienced diarrhea; presence, onset, and severity did not correlate with formulation or dose.

    Search related documents:
    Co phrase search for related documents
    • alkaline phosphatase and bile acid: 1, 2, 3
    • alkaline phosphatase and mg day: 1, 2, 3, 4, 5, 6, 7
    • alkaline phosphatase and mild elevation: 1, 2, 3
    • alkaline phosphatase and serum alkaline phosphatase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • alkaline phosphatase and severity onset: 1
    • alkaline phosphatase and significant abnormality: 1
    • ALP serum alkaline phosphatase and serum alkaline phosphatase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • dose formulation and mg day: 1, 2
    • mg day and mild elevation: 1, 2
    • mg day and oil capsule: 1
    • mg day and serum alkaline phosphatase: 1, 2, 3
    • mg day and severity onset: 1
    • mild elevation and significant abnormality: 1